{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:34:37Z","timestamp":1790710477662,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82004280"],"award-info":[{"award-number":["82004280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104797"],"award-info":[{"award-number":["82104797"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although the prevalence of heart failure with preserved ejection fraction (HFpEF) is growing worldwide, its complex pathophysiology has yet to be fully elucidated, and multiple hypotheses have all failed to produce a viable target for therapeutic action or provide effective treatment. Cardiac remodeling has long been considered an important mechanism of HFpEF. Strong evidence has been reported over the past years that coronary microvascular dysfunction (CMD), manifesting as structural and functional abnormalities of coronary microvasculature, also contributes to the evolution of HFpEF. However, the mechanisms of CMD are still not well understood and need to be studied further. Coronary microvascular endothelial cells (CMECs) are one of the most abundant cell types in the heart by number and active players in cardiac physiology and pathology. CMECs are not only important cellular mediators of cardiac vascularization but also play an important role in disease pathophysiology by participating in the inception and progression of cardiac remodeling. CMECs are also actively involved in the pathogenesis of CMD. Numerous studies have confirmed that CMD is closely related to cardiac remodeling. ECs may serve a critical function in mediating the connection between CMD and HFpEF. It follows that CMECs participate in the mechanism of CMD leading to HFpEF. In this review article, we focus on the role of CMD in the pathogenesis of HFpEF resulting from cardiac remodeling and highlight the subsequent complexity of the EC-mediated correlation between CMD and HFpEF.<\/jats:p>","DOI":"10.1007\/s10741-022-10224-y","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:02:37Z","timestamp":1646841757000},"page":"169-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction"],"prefix":"10.1007","volume":"28","author":[{"given":"Yong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1890-1574","authenticated-orcid":false,"given":"Dufang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"issue":"6","key":"10224_CR1","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/ehf2.12555","volume":"6","author":"D Tomasoni","year":"2019","unstructured":"Tomasoni D, Adamo M, Lombardi CM, Metra M (2019) Highlights in heart failure. ESC Heart Fail 6(6):1105\u20131127. https:\/\/doi.org\/10.1002\/ehf2.12555","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10224_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.21037\/cdt-20-302","volume":"11","author":"RHG Schwinger","year":"2021","unstructured":"Schwinger RHG (2021) Pathophysiology of heart failure. Cardiovasc Diagn Ther 11(1):263\u2013276. https:\/\/doi.org\/10.21037\/cdt-20-302","journal-title":"Cardiovasc Diagn Ther"},{"issue":"5","key":"10224_CR3","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.amjmed.2016.12.031","volume":"130","author":"O Oren","year":"2017","unstructured":"Oren O, Goldberg S (2017) Heart failure with preserved ejection fraction diagnosis and management. Am J Med 130(5):510\u2013516","journal-title":"Am J Med"},{"issue":"6","key":"10224_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.tcm.2018.01.001","volume":"28","author":"A Xanthopoulos","year":"2018","unstructured":"Xanthopoulos A, Triposkiadis F, Starling RC (2018) Heart failure with preserved ejection fraction: classification based upon phenotype is essential for diagnosis and treatment. Trends Cardiovasc Med 28(6):392\u2013400. https:\/\/doi.org\/10.1016\/j.tcm.2018.01.001","journal-title":"Trends Cardiovasc Med"},{"key":"10224_CR5","doi-asserted-by":"publisher","unstructured":"Mohammed SF, Majure DT, Redfield MM (2016) Zooming in on the microvasculature in heart failure with preserved ejection fraction. Circ Heart Fail 9(7). https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.116.003272","DOI":"10.1161\/CIRCHEARTFAILURE.116.003272"},{"issue":"25","key":"10224_CR6","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.2174\/1381612824666180625143232","volume":"24","author":"D Milicic","year":"2018","unstructured":"Milicic D, Jakus N, Fabijanovic D (2018) Microcirculation and Heart Failure. Curr Pharm Des 24(25):2954\u20132959. https:\/\/doi.org\/10.2174\/1381612824666180625143232","journal-title":"Curr Pharm Des"},{"issue":"6","key":"10224_CR7","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1177\/0300060516675504","volume":"45","author":"A Kibel","year":"2017","unstructured":"Kibel A, Selthofer-Relatic K, Drenjancevic I, Bacun T, Bosnjak I, Kibel D et al (2017) Coronary microvascular dysfunction in diabetes mellitus. J Int Med Res 45(6):1901\u20131929. https:\/\/doi.org\/10.1177\/0300060516675504","journal-title":"J Int Med Res"},{"key":"10224_CR8","doi-asserted-by":"crossref","unstructured":"Guarini G, Giuseppina Capozza P, Huqi A, Morrone D, M Chilian W, Marzilli M\u00a0(2013) Microvascular function\/dysfunction downstream a coronary stenosis. Curr Pharm Des 19(13):2366-74","DOI":"10.2174\/1381612811319130004"},{"key":"10224_CR9","doi-asserted-by":"publisher","unstructured":"Vancheri F, Longo G, Vancheri S, Henein M (2020) Coronary microvascular dysfunction. J Clin Med 9(9). https:\/\/doi.org\/10.3390\/jcm9092880","DOI":"10.3390\/jcm9092880"},{"issue":"1","key":"10224_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1253\/circj.CJ-16-1002","volume":"81","author":"C Chen","year":"2016","unstructured":"Chen C, Wei J, AlBadri A, Zarrini P, Bairey Merz CN (2016) Coronary microvascular dysfunction- epidemiology, pathogenesis, prognosis, diagnosis, risk factors and therapy. Circ J 81(1):3\u201311. https:\/\/doi.org\/10.1253\/circj.CJ-16-1002","journal-title":"Circ J"},{"issue":"4","key":"10224_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/cvr\/cvaa023","volume":"116","author":"PG Camici","year":"2020","unstructured":"Camici PG, Tschope C, Di Carli MF, Rimoldi O, Van Linthout S (2020) Coronary microvascular dysfunction in hypertrophy and heart failure. Cardiovasc Res 116(4):806\u2013816. https:\/\/doi.org\/10.1093\/cvr\/cvaa023","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10224_CR12","doi-asserted-by":"publisher","first-page":"H1033","DOI":"10.1152\/ajpheart.00680.2017","volume":"314","author":"K Dryer","year":"2018","unstructured":"Dryer K, Gajjar M, Narang N, Lee M, Paul J, Shah AP et al (2018) Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol 314(5):H1033\u2013H1042. https:\/\/doi.org\/10.1152\/ajpheart.00680.2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"37","key":"10224_CR13","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","volume":"39","author":"SJ Shah","year":"2018","unstructured":"Shah SJ, Lam CSP, Svedlund S, Saraste A, Hage C, Tan RS et al (2018) Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J 39(37):3439\u20133450. https:\/\/doi.org\/10.1093\/eurheartj\/ehy531","journal-title":"Eur Heart J"},{"issue":"10","key":"10224_CR14","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","volume":"39","author":"VR Taqueti","year":"2018","unstructured":"Taqueti VR, Solomon SD, Shah AM, Desai AS, Groarke JD, Osborne MT et al (2018) Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J 39(10):840\u2013849. https:\/\/doi.org\/10.1093\/eurheartj\/ehx721","journal-title":"Eur Heart J"},{"issue":"4","key":"10224_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11897-020-00461-3","volume":"17","author":"A Xanthopoulos","year":"2020","unstructured":"Xanthopoulos A, Dimos A, Giamouzis G, Bourazana A, Zagouras A, Papamichalis M et al (2020) Coexisting morbidities in heart failure: no robust interaction with the left ventricular ejection fraction. Curr Heart Fail Rep 17(4):133\u2013144. https:\/\/doi.org\/10.1007\/s11897-020-00461-3","journal-title":"Curr Heart Fail Rep"},{"issue":"37","key":"10224_CR16","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1093\/eurheartj\/ehy558","volume":"39","author":"J Wei","year":"2018","unstructured":"Wei J, Nelson MD, Sharif B, Shufelt C, Bairey Merz CN (2018) Why do we care about coronary microvascular dysfunction and heart failure with preserved ejection fraction: addressing knowledge gaps for evidence-based guidelines. Eur Heart J 39(37):3451\u20133453. https:\/\/doi.org\/10.1093\/eurheartj\/ehy558","journal-title":"Eur Heart J"},{"key":"10224_CR17","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3389\/fphys.2019.01347","volume":"10","author":"D D'Amario","year":"2019","unstructured":"D\u2019Amario D, Migliaro S, Borovac JA, Restivo A, Vergallo R, Galli M et al (2019) Microvascular dysfunction in heart failure with preserved ejection fraction. Front Physiol 10:1347. https:\/\/doi.org\/10.3389\/fphys.2019.01347","journal-title":"Front Physiol"},{"issue":"4","key":"10224_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.11909\/j.issn.1671-5411.2019.04.002","volume":"16","author":"BH Liu","year":"2019","unstructured":"Liu BH, Li YG, Liu JX, Zhao XJ, Jia Q, Liu CL et al (2019) Assessing inflammation in Chinese subjects with subtypes of heart failure: an observational study of the Chinese PLA Hospital Heart Failure Registry. J Geriatr Cardiol 16(4):313\u2013319. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2019.04.002","journal-title":"J Geriatr Cardiol"},{"key":"10224_CR19","doi-asserted-by":"publisher","unstructured":"Hage C, Michaelsson E, Linde C, Donal E, Daubert JC, Gan LM et al (2017) Inflammatory biomarkers predict heart failure severity and prognosis in patients with heart failure with preserved ejection fraction: a holistic proteomic approach. Circ Cardiovasc Genet 10(1). https:\/\/doi.org\/10.1161\/CIRCGENETICS.116.001633","DOI":"10.1161\/CIRCGENETICS.116.001633"},{"issue":"4","key":"10224_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.numecd.2013.09.021","volume":"24","author":"F Tona","year":"2014","unstructured":"Tona F, Serra R, Di Ascenzo L, Osto E, Scarda A, Fabris R et al (2014) Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease. Nutr Metab Cardiovasc Dis 24(4):447\u2013453. https:\/\/doi.org\/10.1016\/j.numecd.2013.09.021","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"10224_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12471-016-0810-1","volume":"24","author":"L van Heerebeek","year":"2016","unstructured":"van Heerebeek L, Paulus WJ (2016) Understanding heart failure with preserved ejection fraction: where are we today?. Neth Heart J 24(4):227\u2013236. https:\/\/doi.org\/10.1007\/s12471-016-0810-1","journal-title":"Neth Heart J"},{"issue":"25","key":"10224_CR22","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.2174\/1381612824666180711124131","volume":"24","author":"Z Vasiljevic","year":"2018","unstructured":"Vasiljevic Z, Krljanac G, Zdravkovic M, Lasica R, Trifunovic D, Asanin M (2018) Coronary microcirculation in heart failure with preserved systolic function. Curr Pharm Des 24(25):2960\u20132966. https:\/\/doi.org\/10.2174\/1381612824666180711124131","journal-title":"Curr Pharm Des"},{"issue":"7","key":"10224_CR23","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/ejhf.600","volume":"18","author":"F Triposkiadis","year":"2016","unstructured":"Triposkiadis F, Giamouzis G, Parissis J, Starling RC, Boudoulas H, Skoularigis J et al (2016) Reframing the association and significance of co-morbidities in heart failure. Eur J Heart Fail 18(7):744\u2013758. https:\/\/doi.org\/10.1002\/ejhf.600","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10224_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","volume":"4","author":"M Haass","year":"2011","unstructured":"Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM et al (2011) Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the I-PRESERVE trial. Circ Heart Fail 4(3):324\u2013331","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10224_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jcmg.2012.01.020","volume":"5","author":"A Quercioli","year":"2012","unstructured":"Quercioli A, Pataky Z, Montecucco F, Carballo S, Thomas A, Staub C et al (2012) Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation. JACC Cardiovasc Imaging 5(8):805\u2013815. https:\/\/doi.org\/10.1016\/j.jcmg.2012.01.020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10224_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081798","volume":"8","author":"DJ Campbell","year":"2013","unstructured":"Campbell DJ, Somaratne JB, Prior DL, Yii M, Kenny JF, Newcomb AE et al (2013) Obesity is associated with lower coronary microvascular density. PLoS One 8(11):e81798. https:\/\/doi.org\/10.1371\/journal.pone.0081798","journal-title":"PLoS ONE"},{"issue":"10","key":"10224_CR27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cardfail.2016.03.017","volume":"22","author":"A Jaiswal","year":"2016","unstructured":"Jaiswal A, Nguyen VQ, Carry BJ, le Jemtel TH (2016) Pharmacologic and endovascular reversal of left ventricular remodeling. J Card Fail 22(10):829\u2013839. https:\/\/doi.org\/10.1016\/j.cardfail.2016.03.017","journal-title":"J Card Fail"},{"key":"10224_CR28","doi-asserted-by":"publisher","first-page":"8815349","DOI":"10.1155\/2020\/8815349","volume":"2020","author":"W Zhao","year":"2020","unstructured":"Zhao W, Zhao J, Rong J (2020) Pharmacological modulation of cardiac remodeling after myocardial infarction. Oxid Med Cell Longev 2020:8815349. https:\/\/doi.org\/10.1155\/2020\/8815349","journal-title":"Oxid Med Cell Longev"},{"key":"10224_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","volume":"65","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis NG (2019) Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med 65:70\u201399. https:\/\/doi.org\/10.1016\/j.mam.2018.07.001","journal-title":"Mol Aspects Med"},{"issue":"6","key":"10224_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s12265-018-9797-x","volume":"11","author":"Y Li","year":"2018","unstructured":"Li Y, Liang Y, Zhu Y, Zhang Y, Bei Y (2018) Noncoding RNAs in cardiac hypertrophy. J Cardiovasc Transl Res 11(6):439\u2013449. https:\/\/doi.org\/10.1007\/s12265-018-9797-x","journal-title":"J Cardiovasc Transl Res"},{"issue":"4","key":"10224_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62(4):263\u2013271. https:\/\/doi.org\/10.1016\/j.jacc.2013.02.092","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10224_CR32","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.2174\/1381612824666180625125450","volume":"24","author":"A Koller","year":"2018","unstructured":"Koller A, Szenasi A, Dornyei G, Kovacs N, Lelbach A, Kovacs I (2018) Coronary microvascular and cardiac dysfunction due to homocysteine pathometabolism; a complex therapeutic design. Curr Pharm Des 24(25):2911\u20132920. https:\/\/doi.org\/10.2174\/1381612824666180625125450","journal-title":"Curr Pharm Des"},{"issue":"10","key":"10224_CR33","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jcin.2013.05.014","volume":"6","author":"H Kitabata","year":"2013","unstructured":"Kitabata H, Kubo T, Ishibashi K, Komukai K, Tanimoto T, Ino Y et al (2013) Prognostic value of microvascular resistance index immediately after primary percutaneous coronary intervention on left ventricular remodeling in patients with reperfused anterior acute ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 6(10):1046\u20131054. https:\/\/doi.org\/10.1016\/j.jcin.2013.05.014","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10224_CR34","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3349\/ymj.2014.55.4.904","volume":"55","author":"R Cheng","year":"2014","unstructured":"Cheng R, Wei G, Yu L, Su Z, Wei L, Bai X et al (2014) Coronary flow reserve in the remote myocardium predicts left ventricular remodeling following acute myocardial infarction. Yonsei Med J 55(4):904\u2013911. https:\/\/doi.org\/10.3349\/ymj.2014.55.4.904","journal-title":"Yonsei Med J"},{"issue":"8 Pt 2","key":"10224_CR35","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jcmg.2018.10.032","volume":"12","author":"A Gulati","year":"2019","unstructured":"Gulati A, Ismail TF, Ali A, Hsu LY, Goncalves C, Ismail NA et al (2019) Microvascular dysfunction in dilated cardiomyopathy: a quantitative stress perfusion cardiovascular magnetic resonance study. JACC Cardiovasc Imaging 12(8 Pt 2):1699\u20131708. https:\/\/doi.org\/10.1016\/j.jcmg.2018.10.032","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10224_CR36","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1161\/ATVBAHA.121.316025","volume":"41","author":"S Godo","year":"2021","unstructured":"Godo S, Suda A, Takahashi J, Yasuda S, Shimokawa H (2021) Coronary microvascular dysfunction. Arterioscler Thromb Vasc Biol 41(5):1625\u20131637. https:\/\/doi.org\/10.1161\/ATVBAHA.121.316025","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10224_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2021.100777","volume":"34","author":"J Deng","year":"2021","unstructured":"Deng J (2021) Research progress on the molecular mechanism of coronary microvascular endothelial cell dysfunction. Int J Cardiol Heart Vasc 34:100777. https:\/\/doi.org\/10.1016\/j.ijcha.2021.100777","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"17","key":"10224_CR38","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","volume":"35","author":"F Crea","year":"2014","unstructured":"Crea F, Camici PG, Bairey Merz CN (2014) Coronary microvascular dysfunction: an update. Eur Heart J 35(17):1101\u20131111. https:\/\/doi.org\/10.1093\/eurheartj\/eht513","journal-title":"Eur Heart J"},{"issue":"2","key":"10224_CR39","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jcmg.2014.12.008","volume":"8","author":"MA Marinescu","year":"2015","unstructured":"Marinescu MA, Loffler AI, Ouellette M, Smith L, Kramer CM, Bourque JM (2015) Coronary microvascular dysfunction, microvascular angina, and treatment strategies. JACC Cardiovasc Imaging 8(2):210\u2013220. https:\/\/doi.org\/10.1016\/j.jcmg.2014.12.008","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10224_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/MCA.0000000000000599","volume":"29","author":"H Lindemann","year":"2018","unstructured":"Lindemann H, Petrovic I, Hill S, Athanasiadis A, Mahrholdt H, Schaufele T et al (2018) Biopsy-confirmed endothelial cell activation in patients with coronary microvascular dysfunction. Coron Artery Dis 29(3):216\u2013222. https:\/\/doi.org\/10.1097\/MCA.0000000000000599","journal-title":"Coron Artery Dis"},{"issue":"1","key":"10224_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5603\/CJ.a2017.0132","volume":"25","author":"Y Li","year":"2018","unstructured":"Li Y, Zhang H, Liang Y, Wang W, Xu T, Zhang J et al (2018) Effects of hyperbaric oxygen on vascular endothelial function in patients with slow coronary flow. Cardiol J 25(1):106\u2013112. https:\/\/doi.org\/10.5603\/CJ.a2017.0132","journal-title":"Cardiol J"},{"issue":"5","key":"10224_CR42","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/ATVBAHA.119.313704","volume":"40","author":"S Ohura-Kajitani","year":"2020","unstructured":"Ohura-Kajitani S, Shiroto T, Godo S, Ikumi Y, Ito A, Tanaka S et al (2020) Marked impairment of endothelium-dependent digital vasodilatations in patients with microvascular angina: evidence for systemic small artery disease. Arterioscler Thromb Vasc Biol 40(5):1400\u20131412. https:\/\/doi.org\/10.1161\/ATVBAHA.119.313704","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10224_CR43","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.2337\/db12-1025","volume":"62","author":"D Wang","year":"2013","unstructured":"Wang D, Luo P, Wang Y, Li W, Wang C, Sun D et al (2013) Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP\/PKA\/Rho-dependent mechanism. Diabetes 62(5):1697\u20131708. https:\/\/doi.org\/10.2337\/db12-1025","journal-title":"Diabetes"},{"key":"10224_CR44","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.yjmcc.2017.09.007","volume":"112","author":"X He","year":"2017","unstructured":"He X, Zeng H, Chen ST, Roman RJ, Aschner JL, Didion S et al (2017) Endothelial specific SIRT3 deletion impairs glycolysis and angiogenesis and causes diastolic dysfunction. J Mol Cell Cardiol 112:104\u2013113. https:\/\/doi.org\/10.1016\/j.yjmcc.2017.09.007","journal-title":"J Mol Cell Cardiol"},{"key":"10224_CR45","doi-asserted-by":"publisher","first-page":"34199","DOI":"10.1038\/srep34199","volume":"6","author":"J Lin","year":"2016","unstructured":"Lin J, Zhang L, Zhang M, Hu J, Wang T, Duan Y et al (2016) Mst1 inhibits CMECs autophagy and participates in the development of diabetic coronary microvascular dysfunction. Sci Rep 6:34199. https:\/\/doi.org\/10.1038\/srep34199","journal-title":"Sci Rep"},{"key":"10224_CR46","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fphys.2018.00382","volume":"9","author":"VFM Segers","year":"2018","unstructured":"Segers VFM, Brutsaert DL, De Keulenaer GW (2018) Cardiac remodeling: endothelial cells have more to say than just NO. Front Physiol 9:382. https:\/\/doi.org\/10.3389\/fphys.2018.00382","journal-title":"Front Physiol"},{"key":"10224_CR47","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fcell.2020.00569","volume":"8","author":"Z Li","year":"2020","unstructured":"Li Z, Zhang Y, Zhang Y, Yu L, Xiao B, Li T et al (2020) BRG1 Stimulates endothelial derived alarmin MRP8 to promote macrophage infiltration in an animal model of cardiac hypertrophy. Front Cell Dev Biol 8:569. https:\/\/doi.org\/10.3389\/fcell.2020.00569","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10224_CR48","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1111\/jcmm.14900","volume":"24","author":"X Liu","year":"2020","unstructured":"Liu X, Wu J, Zhu C, Liu J, Chen X, Zhuang T et al (2020) Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway. J Cell Mol Med 24(2):2013\u20132026. https:\/\/doi.org\/10.1111\/jcmm.14900","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10224_CR49","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jchf.2015.10.007","volume":"4","author":"C Franssen","year":"2016","unstructured":"Franssen C, Chen S, Unger A, Korkmaz HI, De Keulenaer GW, Tschope C et al (2016) Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction. JACC Heart Fail 4(4):312\u2013324. https:\/\/doi.org\/10.1016\/j.jchf.2015.10.007","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10224_CR50","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1161\/ATVBAHA.115.305230","volume":"35","author":"L Yu","year":"2015","unstructured":"Yu L, Yang G, Weng X, Liang P, Li L, Li J et al (2015) Histone methyltransferase SET1 mediates angiotensin II-induced endothelin-1 transcription and cardiac hypertrophy in mice. Arterioscler Thromb Vasc Biol 35(5):1207\u20131217. https:\/\/doi.org\/10.1161\/ATVBAHA.115.305230","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10224_CR51","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/CIRCULATIONAHA.119.039767","volume":"140","author":"J Liu","year":"2019","unstructured":"Liu J, Zhuang T, Pi J, Chen X, Zhang Q, Li Y et al (2019) Endothelial Forkhead Box transcription factor P1 regulates pathological cardiac remodeling through transforming growth factor-beta1-endothelin-1 signal pathway. Circulation 140(8):665\u2013680. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.039767","journal-title":"Circulation"},{"issue":"13\u201314","key":"10224_CR52","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.lfs.2012.02.006","volume":"91","author":"S Adiarto","year":"2012","unstructured":"Adiarto S, Heiden S, Vignon-Zellweger N, Nakayama K, Yagi K, Yanagisawa M et al (2012) ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy. Life Sci 91(13\u201314):651\u2013657. https:\/\/doi.org\/10.1016\/j.lfs.2012.02.006","journal-title":"Life Sci"},{"key":"10224_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.yjmcc.2014.11.009","volume":"80","author":"X Weng","year":"2015","unstructured":"Weng X, Yu L, Liang P, Chen D, Cheng X, Yang Y et al (2015) Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy. J Mol Cell Cardiol 80:23\u201333. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.11.009","journal-title":"J Mol Cell Cardiol"},{"issue":"22","key":"10224_CR54","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1161\/CIRCULATIONAHA.118.036099","volume":"139","author":"R Kivela","year":"2019","unstructured":"Kivela R, Hemanthakumar KA, Vaparanta K, Robciuc M, Izumiya Y, Kidoya H et al (2019) Endothelial cells regulate physiological cardiomyocyte growth via VEGFR2-mediated paracrine signaling. Circulation 139(22):2570\u20132584. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036099","journal-title":"Circulation"},{"issue":"1","key":"10224_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1074248420952233","volume":"26","author":"W Cheng","year":"2021","unstructured":"Cheng W, Li X, Liu D, Cui C, Wang X (2021) Endothelial-to-mesenchymal transition: role in cardiac fibrosis. J Cardiovasc Pharmacol Ther 26(1):3\u201311. https:\/\/doi.org\/10.1177\/1074248420952233","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10224_CR56","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.semcdb.2019.10.015","volume":"101","author":"X Sun","year":"2020","unstructured":"Sun X, Nkennor B, Mastikhina O, Soon K, Nunes SS (2020) Endothelium-mediated contributions to fibrosis. Semin Cell Dev Biol 101:78\u201386. https:\/\/doi.org\/10.1016\/j.semcdb.2019.10.015","journal-title":"Semin Cell Dev Biol"},{"key":"10224_CR57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.lfs.2017.07.014","volume":"184","author":"H Gong","year":"2017","unstructured":"Gong H, Lyu X, Wang Q, Hu M, Zhang X (2017) Endothelial to mesenchymal transition in the cardiovascular system. Life Sci 184:95\u2013102. https:\/\/doi.org\/10.1016\/j.lfs.2017.07.014","journal-title":"Life Sci"},{"key":"10224_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fcvm.2020.00053","volume":"7","author":"PY Chen","year":"2020","unstructured":"Chen PY, Schwartz MA, Simons M (2020) Endothelial-to-mesenchymal transition, vascular inflammation, and atherosclerosis. Front Cardiovasc Med 7:53. https:\/\/doi.org\/10.3389\/fcvm.2020.00053","journal-title":"Front Cardiovasc Med"},{"key":"10224_CR59","doi-asserted-by":"crossref","unstructured":"S G, C C-V, F. S (2018) Transforming growth factor-beta family: advances in vascular function and signaling. Curr Protein Pept Sci 19(12):1164-71","DOI":"10.2174\/1389203719666171128114730"},{"issue":"10","key":"10224_CR60","doi-asserted-by":"publisher","first-page":"595","DOI":"10.5483\/BMBRep.2019.52.10.206","volume":"52","author":"L Xu","year":"2019","unstructured":"Xu L, Fu M, Chen D, Han W, Ostrowski MC, Grossfeld P et al (2019) Endothelial-specific deletion of Ets-1 attenuates angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition. BMB Rep 52(10):595\u2013600. https:\/\/doi.org\/10.5483\/BMBRep.2019.52.10.206","journal-title":"BMB Rep"},{"issue":"6","key":"10224_CR61","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1128\/MCB.01074-15","volume":"36","author":"A Frias","year":"2015","unstructured":"Frias A, Lambies G, Vinas-Castells R, Martinez-Guillamon C, Dave N, Garcia de Herreros A et al (2015) A Switch in Akt isoforms is required for notch-induced snail1 expression and protection from cell death. Mol Cell Biol 36(6):923\u2013940. https:\/\/doi.org\/10.1128\/MCB.01074-15","journal-title":"Mol Cell Biol"},{"issue":"27","key":"10224_CR62","doi-asserted-by":"publisher","first-page":"16653","DOI":"10.1074\/jbc.M115.636944","volume":"290","author":"X Xu","year":"2015","unstructured":"Xu X, Tan X, Tampe B, Sanchez E, Zeisberg M, Zeisberg EM (2015) Snail is a direct target of hypoxia-inducible factor 1alpha (HIF1alpha) in hypoxia-induced endothelial to mesenchymal transition of human coronary endothelial cells. J Biol Chem 290(27):16653\u201316664. https:\/\/doi.org\/10.1074\/jbc.M115.636944","journal-title":"J Biol Chem"},{"issue":"1","key":"10224_CR63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3892\/ijmm.2017.2998","volume":"40","author":"Y Liu","year":"2017","unstructured":"Liu Y, Zou J, Li B, Wang Y, Wang D, Hao Y et al (2017) RUNX3 modulates hypoxia-induced endothelial-to-mesenchymal transition of human cardiac microvascular endothelial cells. Int J Mol Med 40(1):65\u201374. https:\/\/doi.org\/10.3892\/ijmm.2017.2998","journal-title":"Int J Mol Med"},{"issue":"8","key":"10224_CR64","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41569-019-0176-3","volume":"16","author":"N Dhaun","year":"2019","unstructured":"Dhaun N, Webb DJ (2019) Endothelins in cardiovascular biology and therapeutics. Nat Rev Cardiol 16(8):491\u2013502. https:\/\/doi.org\/10.1038\/s41569-019-0176-3","journal-title":"Nat Rev Cardiol"},{"key":"10224_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-021-09581-5","author":"X Zhang","year":"2021","unstructured":"Zhang X, Hu C, Yuan YP, Song P, Kong CY, Wu HM et al (2021) Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism. Cell Biol Toxicol. https:\/\/doi.org\/10.1007\/s10565-021-09581-5","journal-title":"Cell Biol Toxicol"},{"issue":"Suppl 1","key":"10224_CR66","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.rmed.2016.08.022","volume":"122","author":"P Sandner","year":"2017","unstructured":"Sandner P, Stasch JP (2017) Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence. Respir Med 122(Suppl 1):S1\u2013S9. https:\/\/doi.org\/10.1016\/j.rmed.2016.08.022","journal-title":"Respir Med"},{"issue":"9","key":"10224_CR67","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1038\/mt.2013.146","volume":"21","author":"SW Lee","year":"2013","unstructured":"Lee SW, Won JY, Kim WJ, Lee J, Kim KH, Youn SW et al (2013) Snail as a potential target molecule in cardiac fibrosis: paracrine action of endothelial cells on fibroblasts through snail and CTGF axis. Mol Ther 21(9):1767\u20131777. https:\/\/doi.org\/10.1038\/mt.2013.146","journal-title":"Mol Ther"},{"key":"10224_CR68","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.niox.2019.09.002","volume":"93","author":"RH Yang","year":"2019","unstructured":"Yang RH, Tan X, Ge LJ, Sun JC, Peng XD, Wang WZ (2019) Interleukin enhancement binding factor 3 inhibits cardiac hypertrophy by targeting asymmetric dimethylarginine-nitric oxide. Nitric Oxide 93:44\u201352. https:\/\/doi.org\/10.1016\/j.niox.2019.09.002","journal-title":"Nitric Oxide"},{"issue":"2","key":"10224_CR69","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1142\/S0192415X11008890","volume":"39","author":"P Chan","year":"2011","unstructured":"Chan P, Liu JC, Lin LJ, Chen PY, Cheng TH, Lin JG et al (2011) Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts. Am J Chin Med 39(2):381\u2013394. https:\/\/doi.org\/10.1142\/S0192415X11008890","journal-title":"Am J Chin Med"},{"issue":"3","key":"10224_CR70","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.ijcard.2013.01.165","volume":"168","author":"J Gravning","year":"2013","unstructured":"Gravning J, Ahmed MS, von Lueder TG, Edvardsen T, Attramadal H (2013) CCN2\/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload. Int J Cardiol 168(3):2049\u20132056. https:\/\/doi.org\/10.1016\/j.ijcard.2013.01.165","journal-title":"Int J Cardiol"},{"key":"10224_CR71","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jep.2017.01.033","volume":"202","author":"H Qu","year":"2017","unstructured":"Qu H, Wang Y, Wang Y, Yang T, Feng Z, Qu Y et al (2017) Luhong formula inhibits myocardial fibrosis in a paracrine manner by activating the gp130\/JAK2\/STAT3 pathway in cardiomyocytes. J Ethnopharmacol 202:28\u201337. https:\/\/doi.org\/10.1016\/j.jep.2017.01.033","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10224_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10741-018-9720-1","volume":"24","author":"E Tarbit","year":"2019","unstructured":"Tarbit E, Singh I, Peart JN, Rose\u2019Meyer RB (2019) Biomarkers for the identification of cardiac fibroblast and myofibroblast cells. Heart Fail Rev 24(1):1\u201315. https:\/\/doi.org\/10.1007\/s10741-018-9720-1","journal-title":"Heart Fail Rev"},{"issue":"2","key":"10224_CR73","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3892\/ijmm.2014.1781","volume":"34","author":"L Si","year":"2014","unstructured":"Si L, Xu J, Yi C, Xu X, Wang F, Gu W et al (2014) Asiatic acid attenuates cardiac hypertrophy by blocking transforming growth factor-beta1-mediated hypertrophic signaling in vitro and in vivo. Int J Mol Med 34(2):499\u2013506. https:\/\/doi.org\/10.3892\/ijmm.2014.1781","journal-title":"Int J Mol Med"},{"key":"10224_CR74","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.biopha.2017.07.104","volume":"95","author":"H Zhang","year":"2017","unstructured":"Zhang H, Hu J, Liu L (2017) MiR-200a modulates TGF-beta1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs. Biomed Pharmacother 95:215\u2013222. https:\/\/doi.org\/10.1016\/j.biopha.2017.07.104","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10224_CR75","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3892\/etm.2017.5448","volume":"15","author":"X Wei","year":"2018","unstructured":"Wei X, Yang Y, Jiang YJ, Lei JM, Guo JW, Xiao H (2018) Relaxin ameliorates high glucose-induced cardiomyocyte hypertrophy and apoptosis via the Notch1 pathway. Exp Ther Med 15(1):691\u2013698. https:\/\/doi.org\/10.3892\/etm.2017.5448","journal-title":"Exp Ther Med"},{"issue":"5","key":"10224_CR76","doi-asserted-by":"publisher","first-page":"739","DOI":"10.33549\/physiolres.932149","volume":"60","author":"YH Fan","year":"2011","unstructured":"Fan YH, Dong H, Pan Q, Cao YJ, Li H, Wang HC (2011) Notch signaling may negatively regulate neonatal rat cardiac fibroblast-myofibroblast transformation. Physiol Res 60(5):739\u2013748. https:\/\/doi.org\/10.33549\/physiolres.932149","journal-title":"Physiol Res"},{"key":"10224_CR77","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.2147\/DDDT.S85399","volume":"9","author":"X Zhou","year":"2015","unstructured":"Zhou X, Chen X, Cai JJ, Chen LZ, Gong YS, Wang LX et al (2015) Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway. Drug Des Devel Ther 9:4599\u20134611. https:\/\/doi.org\/10.2147\/DDDT.S85399","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10224_CR78","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12931-019-1100-4","volume":"20","author":"A Aquino-Galvez","year":"2019","unstructured":"Aquino-Galvez A, Gonzalez-Avila G, Jimenez-Sanchez LL, Maldonado-Martinez HA, Cisneros J, Toscano-Marquez F et al (2019) Dysregulated expression of hypoxia-inducible factors augments myofibroblasts differentiation in idiopathic pulmonary fibrosis. Respir Res 20(1):130. https:\/\/doi.org\/10.1186\/s12931-019-1100-4","journal-title":"Respir Res"},{"issue":"8","key":"10224_CR79","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/1873-3468.12158","volume":"590","author":"X Xu","year":"2016","unstructured":"Xu X, Tan X, Hulshoff MS, Wilhelmi T, Zeisberg M, Zeisberg EM (2016) Hypoxia-induced endothelial-mesenchymal transition is associated with RASAL1 promoter hypermethylation in human coronary endothelial cells. FEBS Lett 590(8):1222\u20131233. https:\/\/doi.org\/10.1002\/1873-3468.12158","journal-title":"FEBS Lett"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-022-10224-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-022-10224-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-022-10224-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T01:10:56Z","timestamp":1675645856000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-022-10224-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["10224"],"URL":"https:\/\/doi.org\/10.1007\/s10741-022-10224-y","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"assertion":[{"value":"23 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}